Don’t Expose Empty Vials to Uncontrolled Environments in GMP Settings
Remember: Never leave empty sterile vials exposed in unclassified or uncontrolled environments — they are highly vulnerable to contamination.
Why This Matters in GMP
Empty sterile vials are critical components in aseptic processing, designed to maintain sterility until the point of use. Once depyrogenated or sterilized, even momentary exposure to uncontrolled environments can allow microbial or particulate ingress, rendering the vials unsuitable for use. These contaminants are difficult to detect visually and can jeopardize the sterility of the final product.
For example, if a rack of sterile vials is staged near an HVAC exhaust vent in an unclassified corridor before filling, the turbulent airflow may deposit particulates or microorganisms into the vial openings. This can result in batch contamination, sterility test failures, or patient safety risks if undetected.
Regulatory and Compliance Implications
21 CFR Part 211.113 requires procedures to prevent microbiological contamination in sterile drug products. EU GMP Annex 1 specifies that containers must be protected from exposure to environments of lower classification. WHO GMP mandates that sterile materials be handled only within designated classified areas.
Auditors examine vial handling practices, transfer protocols, and area classifications.
Implementation Best Practices
Always transport and store sterile vials within Grade A/B environments or use validated closed containers. Cover open vials with sterile caps or sterile wrapping if temporarily staged. Define clear SOPs for handling, exposure limits, and time constraints. Use pass boxes or controlled airlocks when moving between classified zones.
Train staff on the risks of uncontrolled exposure and conduct regular audits of vial staging areas. Link vial exposure practices to deviation protocols if any excursions occur, and trend such events as part of aseptic process risk assessments.
Regulatory References
– 21 CFR Part 211.113 – Sterile drug contamination prevention
– EU GMP Annex 1 – Container handling and cleanroom exposure
– WHO TRS 961, Annex 6 – Handling of sterile components
– PDA TR #77 – Vial Management in Aseptic Processing